Clinical usefulness of microarrays for cancer prognosis in 2010 - Letter

Clinical Cancer Research

Volumn 16, Issue 24, 2010, Pages 6180-

  Koscielny, Serge ^a   Michiels, Stefan ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BREAST CANCER; CANCER GRADING; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; HUMAN; LETTER; MICROARRAY ANALYSIS; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VALIDATION STUDIES AS TOPIC;

EID: 78650355869     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1249     Document Type: Letter

References (5)

1. Fan X, Shi L, Fang H, Cheng Y, Perkins R, Tong W. DNA microarrays are predictive of cancer prognosis: a re-evaluation. Clin Cancer Res 2010; 16:629-36.
2. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365:488-92.
3. Michiels S, Koscielny S, Hill C. Interpretation of microarray data in cancer. Br J Cancer 2007;96:1155-8.
4. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, et al. TRANSBIG consortium. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183-92.
5. Koscielny S., Why most gene expression signatures of tumors have not been useful in the clinic. Sci Transl Med 2010;2:14ps2.